+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Tuberous Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Hyperinsulinism - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Hyperinsulinism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Argininosuccinic Aciduria - Pipeline Insight, 2025 - Product Thumbnail Image

Argininosuccinic Aciduria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Bardet-Biedl Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Bardet-Biedl Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Central Precocious Puberty - Pipeline Insight, 2025 - Product Thumbnail Image

Central Precocious Puberty - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Alzheimer's-disease - Pipeline Insight, 2025 - Product Thumbnail Image

Alzheimer's-disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Central Serous Chorioretinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Central Serous Chorioretinopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Gaucher's Disease Type I - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type I - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease Type III - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type III - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lewy Body Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MPYS Protein Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

MPYS Protein Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
TrkC Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

TrkC Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Marburg Virus Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Marburg Virus Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Complement 3 Glomerulopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vernal Keratoconjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Vernal Keratoconjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hunter Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hunter Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angelman Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Angelman Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dopamine D1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Dopamine D1 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more